CRT 2017: ACS & AMI Management - ACS Pharmacotherapy

Conference
A session on ACS Pharmacotherapy from CRT 2017

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Overview

ACS & AMI Management - ACS Pharmacotherapy
12 Expert Sessions

Featuring

  • Manesh Patel
  • Anthony Bavry
  • Gary Schaer
  • David Moliterno
  • Roxana Mehran 
  • Dominick Angiolillo
  • Michael Lipinski
  • Patrick Serruys
  • Usman Baber
  • Paul Gurbel

Add this Moment to your Passport

Learn from this moment and keep it forever.
Add To Passport
$19.99
This moment is included in Simple Premium - Get started for free.
FREE with Simple Premium
Start your 30-day free trial
Simple Premium offers unlimited access to all premium moments. $30.00 per month. Cancel anytime.

Moment Components

ACS/PCI Guidelines and AUC Update: What Is New? - Manesh Patel
Is There A Role for Bivalirudin During PCI in Stable CAD? - Anthony Bavry
Use of Cangrelor in ACS - Case Presentations - Gary Schaer
Polypharmacy Anticoagulation - AF meets PCI
How Will PIONEER AF-PCI Change Our Practice? - Roxana Mehran
When to Switch and How to Switch Antiplatelet Therapy - Dominick Angiolillo
The Use of IIb/IIIa Inhibitors in ACS Patients - Michael Lipinski
NOACS for ACS: Is There a Role? - Roxana Mehran
Monotherapy for Stable Patients the Way to Go (Global Freedom) - Patrick Serruys
Updated North American Consensus on Antithrombotic Therapy in Patients With Atrial Fibrillation Undergoing PCI - Dominick Angiolillo
Monotherapy After 3 Months TWILIGHT (update) - Usman Baber
Is There a Role for Antiplatelet or Genetic Testing to Tailor Antiplatelet Therapy in 2017? - Paul Gurbel

Target Audience

  • Cardiologists
  • Interventional Cardiologists
  • Interventional Fellows
  • Interventional Radiologists
  • Vascular Surgeons
  • Emergency Physicians
  • Physicians with an interest in Cardiovascular Innovations

Learning Objectives

Updates on ACS Pharmacology

Related Moments

CRT 2016 Valve & Structural - The Mitraclip Workshop - Show Me the Data
Conference
Mitraclip Workshop at CRT 2016 (Sponsored by Abbott Vascular)
Supported By
CRT 2016 Coronary - Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate
Conference
Session on Antiplatelet Responsiveness, Genetics, Genomics and Drug-to-Drug Interactions: The Great Debate at CRT 2016
Major Bleeding And Adverse Outcome Following Percutaneous Coronary Intervention
Journal
Article on Major Bleeding And Adverse Outcome Following Percutaneous Coronary Intervention
Loading Simple Education